Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALPL | P05186 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30155444 | 0.97 | ALPL (0.34) | ALPL | |
| SCHEMBL4779310 | 0.80 | ALPL (0.33) | ALPL | |
| SCHEMBL14102795 | 0.80 | — | — | |
| Tert-Butyl Formate SCHEMBL28292276 | 0.78 | TDP1 (0.42) | — | |
| SCHEMBL31126125 | 0.77 | — | — | |
| SCHEMBL27931030 | 0.77 | HSD17B10 (0.39) | ALPL | |
| SCHEMBL1694487 | 0.76 | — | — | |
| SCHEMBL28200979 | 0.76 | — | — | |
| SCHEMBL31043086 | 0.75 | — | — | |
| SCHEMBL27795217 | 0.73 | GAA (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110292867-A | A kind of high throughput organic solvent-resistant nanofiltration gel compound membrane and preparation method thereof | 王哲 | 2019-10-01 | — | — | CN | claimed |
| EP-4703326-A1 | METHOD FOR RECOVERING ALKALI METAL SALT AND APPARATUS FOR RECOVERING ALKALI METAL SALT | Toray Industries, Inc. (JP) | 2026-03-04 | — | — | EP | disclosed |
| EP-4628609-A1 | METHOD FOR RECOVERING ALKALI METAL SALT AND APPARATUS FOR RECOVERING ALKALI METAL SALT | Toray Industries, Inc. (JP) | 2025-10-08 | — | — | EP | disclosed |
| EP-4628199-A1 | COMPOSITE SEMIPERMEABLE MEMBRANE, COMPOSITE SEMIPERMEABLE MEMBRANE ELEMENT, AND FILTER DEVICE | Toray Industries, Inc. (JP) | 2025-10-08 | — | — | EP | disclosed |
| WO-2025070624-A1 | METHOD AND DEVICE FOR RECOVERING ALKALI METAL IONS AND HYDROXIDE IONS | 東レ株式会社 | 2025-04-03 | — | — | WO | disclosed |
| WO-2024225409-A1 | METHOD FOR RECOVERING ALKALI METAL SALT AND APPARATUS FOR RECOVERING ALKALI METAL SALT | 東レ株式会社 | 2024-10-31 | — | — | WO | disclosed |
| WO-2024117238-A1 | COMPOSITE SEMIPERMEABLE MEMBRANE, COMPOSITE SEMIPERMEABLE MEMBRANE ELEMENT, AND FILTER DEVICE | 東レ株式会社 | 2024-06-06 | — | — | WO | disclosed |
| WO-2024117236-A1 | METHOD FOR RECOVERING ALKALI METAL SALT AND APPARATUS FOR RECOVERING ALKALI METAL SALT | 東レ株式会社 | 2024-06-06 | — | — | WO | disclosed |
| WO-2021085600-A1 | COMPOSITE SEMIPERMEABLE MEMBRANE AND MANUFACTURING METHOD THEREFOR | 東レ株式会社 | 2021-05-06 | — | — | WO | disclosed |
| CN-106387370-A | PROCESS FOR MAKING A PET FOOD IN THE FORM OF A COATED KIBBLE | 马斯公司 | 2017-02-15 | — | — | CN | disclosed |
| US-20080076924-A1 | Piperazines as P2X7 antagonists | ABBOTT LABORATORIES | 2008-03-27 | — | — | US | disclosed |
| US-20080076924-A1 | Piperazines as P2X7 antagonists | ABBOTT LABORATORIES | 2008-03-27 | — | — | US | disclosed |
| CN-1127406-C | Laminated film and vapor deposition film using the same | TORAY INDUSTRIES (JP) | 2003-11-12 | — | — | CN | disclosed |
| CN-1319048-A | Laminated film and vapor deposition film using the same | TORAY INDUSTRIES (JP) | 2001-10-24 | — | — | CN | disclosed |
| EP-0638073-B1 | 1-PIPERAZINO-1,2-DIHYDROINDENE DERIVATIVES | LUNDBECK & CO AS H (DK) | 2000-06-21 | — | — | EP | disclosed |
| US-5807855-A | ANTAGONIST OF DOPAMINE RECEPTORS; CENTRAL NERVOUS SYSTEM DISORDERS | H. LUNDBECK A/S (DK) | 1998-09-15 | — | — | US | disclosed |
| EP-0638073-A1 | 1-PIPERAZINO-1,2-DIHYDROINDENE DERIVATIVES | H. LUNDBECK A/S (DK) | 1995-02-15 | — | — | EP | disclosed |
| WO-1993022293-A1 | 1-PIPERAZINO-1,2-DIHYDROINDENE DERIVATIVES | H. LUNDBECK A/S (DK) | 1993-11-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080076924-A1 | Piperazines as P2X7 antagonists | P2RX7, P2RX1, P2RX2 | ALPL 3816/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.